An easy method to determine crucial #AMEI performance parameters from clinical routine data in individuals – Part 2: #dynamicrange #OpenAccess #NewArticle #IJA by Busch, Lenarz & Hannes Maier #AuDpeeps #Audiology https://lnkd.in/dHb3J-K4
International Journal of Audiology’s Post
More Relevant Posts
-
Patient journeys are so powerful and a reminder of why we come to work each day.
At Prothena, we recognize the profound impact of sharing firsthand experiences to drive awareness and understanding of medical conditions. Delve into Linda's journey with #amyloidosis in which she not only sheds light on the challenges faced by those living with this #raredisease, but also shares advice for others. Learn more: https://bit.ly/4e0e9qB
-
-
Learn effective approaches to evaluate and diagnose prurigo nodularis in this expert presentation from renowned expert Nicholas Mollanazar, MD, MBA. #ad Watch here: https://ow.ly/QMgN50SZGIR
-
-
Today we celebrate innovation with Velatura Public Benefit Corporation to make a meaningful difference on the front line of healthcare. Physicians and Health Systems struggle with the heavy work of prior authorizations. There are fleets of talented revenue cycle professionals working the circuitous and often confusing systems to get patients authorized for care. Have you ever needed care desperately, but had to wait "until we hear if this test or treatment is authorized?" Velatura Public Benefit Corporation and Spesana are aligned in streamlining processes with advanced technology, speeding the tasks and answers for clinicians, and supporting all parties with a hand in providing care to patients. It's an honor to do hard work with the team at Spesana and Velatura Public Benefit Corporation! #precisionmedicine #patientcare #physicianburnout #ihatecancer
Spesana and Velatura today announced a pilot project that will revolutionize prior authorization for oncologists and specialty medicine providers. In this joint effort, Spesana's Authorize tool will allow oncologists to expedite prior authorization requests, ensuring swift approvals required for advanced therapies and treatment options that would typically be delayed or rejected by the prior authorization process. As the collaboration between Velatura and Spesana widens, oncologists will have unprecedented and fully interoperable access to their patients’ comprehensive medical records at the point of care, empowering them to make informed decisions and create treatment plans that are efficient, scalable, and personalized from diagnosis through survivorship. Read more here ⬇ #priorauthorization #interoperability #precisionmedicine https://lnkd.in/gCTyhatu
-
Gonioscopy is an Eye Examination Technique to view the Iridocorneal Angle | Dr. Nidhi Gupta #eyes #gonioscopy, #eyetest #gonioscopyanglestructures #drnidhigupta #delhieyecare
-
Spesana constantly improving patient care! Eligibility Patient Financial Responsibility Prior Authorization will be no obstacles in providing the best care! #cancerawareness #cancertreatment #healthcare #priorauthorization #precisionmedicine #oncology #patientcare #patientengagement
Spesana and Velatura today announced a pilot project that will revolutionize prior authorization for oncologists and specialty medicine providers. In this joint effort, Spesana's Authorize tool will allow oncologists to expedite prior authorization requests, ensuring swift approvals required for advanced therapies and treatment options that would typically be delayed or rejected by the prior authorization process. As the collaboration between Velatura and Spesana widens, oncologists will have unprecedented and fully interoperable access to their patients’ comprehensive medical records at the point of care, empowering them to make informed decisions and create treatment plans that are efficient, scalable, and personalized from diagnosis through survivorship. Read more here ⬇ #priorauthorization #interoperability #precisionmedicine https://lnkd.in/gCTyhatu
-
Late breaking clinical data! EMERGE LAA: Real-world data for the Amplatzer Amulet LAA Occluder demonstrates 96% implant success, 97% clinically relevant closure at 45 days, > 90% freedom from OACs and a safety endpoint < 1%. Learn more about Amulet: https://abbo.tt/amulet Safety Info: https://abbo.tt/AmuletISI #ClinicalData #AFSymposium2024 #Amplatzer #Amulet
-
SENTIERO ADVANCED IS THE TECHNOLOGY LEADER ! If you are searching for OAE Diagnostic modules, Sentiero Advanced should be your choice. - TEOAE Diagnostic module Provides diagnostic TEOAE testing between 1 and 4kHz and can be configured to set user defined stop criteria, (3, 4 or 5 out of 5 frequency bands) and settable signal to noise ratio (SNR) of 6 or 9dB. - DPOAE Diagnostic module Provides testing up to 10kHz with fast multi-channel DPOAE and FMDPOAE® and up to 30 points per octave resolution. - DPOAE Threshold Estimation module Uses patented PATH technology to provide an estimated audiogram from the DPOAE response.. This is extremely useful in non-cooperative patients providing objective measurements quickly and accurately. #PATH_MEDICAL #SENTIERO_ADVANCED #Technology_Leader #Audiology #Audiologist
-
-
doctor e2 graph.md points of view
-
Don't miss out on valuable insights from experts like Ivaan Gabric, MD, from Eye Clinic Svetjlost, Croatia, as they discuss the benefits of the SCHWIND ATOS. Learn about the adoption of lenticule extraction in a high-volume clinic and how it can benefit you. Watch the full presentation by following the link below! https://hubs.li/Q02nNpkl0 #schwind #schwindlaser #ophthalmology #refractive #schwindatos #smartsight
-
-
ARTICLE PUBLICATION 😌😊 PARTIAL EXTRACTION THERAPY:A SAVIOUR IN ESTHETIC ZONE Final Published Article😅(though i posted earlier only accepted front page of the article) Hearlfelt thanks to my HOD Dr.Anil Melath sir,My guide Dr.Subair and my Professors Dr.Arjun,Dr.Mahesh for their constant support during surgical procedure. Thanks once again to my better half both in career and personal Dr. Abirami vaithilingam for making this article publication #Scientificpublication #CaseReportPublication #Healthcare
